137 related articles for article (PubMed ID: 11985373)
1. Highlights of the 22nd French pharmacovigilance meeting.
Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
[TBL] [Abstract][Full Text] [Related]
2. 19th French pharmacovigilance meeting. Health professionals and consumers are inadequately informed.
Prescrire Int; 1998 Dec; 7(38):188-90. PubMed ID: 10848054
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
Castot A; Bidault I; Dahan R; Efthymiou ML
Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
[TBL] [Abstract][Full Text] [Related]
5. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Olivier P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
[TBL] [Abstract][Full Text] [Related]
6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
7. New drugs: watch out for unexpected adverse effects.
Prescrire Int; 2002 Oct; 11(61):150-1. PubMed ID: 12378747
[TBL] [Abstract][Full Text] [Related]
8. ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].
Abadie D; Durrieu G; Roussin A; Montastruc JL;
Therapie; 2013; 68(2):77-84. PubMed ID: 23773348
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced taste disorders: analysis of the French Pharmacovigilance Database and literature review].
Ratrema M; Guy C; Nelva A; Benedetti C; Beyens MN; Grasset L; Ollagnier M;
Therapie; 2001; 56(1):41-50. PubMed ID: 11322016
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacovigilance of self-medication].
Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
[TBL] [Abstract][Full Text] [Related]
12. [Post licensure safety surveillance for Prevenar].
Bensouda-Grimaldi L; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2007 Jul; 14(7):870-4. PubMed ID: 17442548
[TBL] [Abstract][Full Text] [Related]
13. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
Aguirre C; Haramburu F
Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
[TBL] [Abstract][Full Text] [Related]
14. [Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].
Benedetti-Bardet C; Guy C; Boudignat O; Regnier-Zerbib A; Ollagnier M;
Therapie; 2001; 56(3):295-9. PubMed ID: 11475811
[TBL] [Abstract][Full Text] [Related]
15. [Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
Auriche M; Bertrand P; Blay N; Danan G; Hamel JD; Imbs JL; Lagier G; Micaleff A; Moore N; Ollagnier M; Reveilleau-Richard S; Soubrié C; Weber F
Therapie; 1997; 52(2):123-7. PubMed ID: 9231506
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacovigilance of vaccines].
Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
[TBL] [Abstract][Full Text] [Related]
19. [Vaccines pharmacovigilance].
Autret-Leca E; Jonville-Béra AP; Beau-Salinas F
Rev Prat; 2004 Mar; 54(5):526-31. PubMed ID: 15176512
[TBL] [Abstract][Full Text] [Related]
20. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
Mazé F; Bégaud B
Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
